Sinopharm Group Co (1099) Price & Analysis

Compare

6 Followers

1099 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$16.02 - HK$23.65

Previous CloseN/A

Volume3.49M

Average Volume (3M)6.80M

Market Cap

$58.82B

Enterprise ValueN/A

Total Cash (Recent Filing)$54.31B

Total Debt (Recent Filing)¥76.39B

Price to Earnings (P/E)7.6

Beta0.75

Next Earnings

Sep 01, 2025

EPS Estimate

1.04

Next Dividend Ex-Date

Jun 16, 2025

Dividend Yield5.6%

Share Statistics

EPS (TTM)2.45

Shares Outstanding1,341,810,800

10 Day Avg. Volume7,040,808

30 Day Avg. Volume6,796,577

Financial Highlights & Ratios

PEG Ratio-0.40

Price to Book (P/B)0.68

Price to Sales (P/S)0.00

P/FCF Ratio5.87

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$23.38

Price Target Upside25.03% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Sinopharm Group Co News

PremiumCompany Announcements

Sinopharm Group Announces 2024 AGM with Key Resolutions

16d ago

PremiumCompany Announcements

Sinopharm Group Announces Share Repurchase Mandate

16d ago

PremiumCompany Announcements

Sinopharm Group Proposes H Share Repurchase Mandate

16d ago

PremiumCompany Announcements

Sinopharm Group Announces Board of Directors and Committee Roles

22d ago

PremiumCompany Announcements

Sinopharm Announces Board Changes with New Director Appointment

22d ago

PremiumCompany Announcements

Sinopharm Group Reports Q1 2025 Financial Results

1M ago

PremiumCompany Announcements

Sinopharm Announces Board Changes with New Director Appointment

1M ago

PremiumCompany Announcements

Sinopharm Group Reports Q1 2025 Financial Results

1M ago

See All HK:1099 News

See All News >

Bulls Say, Bears Say

Bulls Say

Market PositionContinuous market share gains from industry consolidation could make Sinopharm remain the largest drug distributor in China and expand its market share significantly.

Operational EfficiencyA new policy allows medical institutes to apply for funds for payment to suppliers in advance, speeding up pharm distributor payments.

Bears Say

Earnings Performance1H24 earnings dropped by 10% y/y, below expectation.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

13.84%

Mutual Funds

― Other Institutional Investors

77.02% Public Companies and

Individual Investors

Detailed Ownership Overview >

1099 FAQ

What was Sinopharm Group Co Ltd Class H’s price range in the past 12 months?

Sinopharm Group Co Ltd Class H lowest stock price was HK$16.02 and its highest was HK$23.65 in the past 12 months.

What is Sinopharm Group Co Ltd Class H’s market cap?

Sinopharm Group Co Ltd Class H’s market cap is $58.82B.

When is Sinopharm Group Co Ltd Class H’s upcoming earnings report date?

Sinopharm Group Co Ltd Class H’s upcoming earnings report date is Sep 01, 2025 which is in 86 days.

How were Sinopharm Group Co Ltd Class H’s earnings last quarter?

Sinopharm Group Co Ltd Class H released its earnings results on Apr 25, 2025. The company reported HK$0.505 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.505.

Is Sinopharm Group Co Ltd Class H overvalued?

According to Wall Street analysts Sinopharm Group Co Ltd Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Sinopharm Group Co Ltd Class H pay dividends?

Sinopharm Group Co Ltd Class H pays a Annually dividend of HK$0.729 which represents an annual dividend yield of 5.6%. See more information on Sinopharm Group Co Ltd Class H dividends here

What is Sinopharm Group Co Ltd Class H’s EPS estimate?

Sinopharm Group Co Ltd Class H’s EPS estimate is 1.04.

How many shares outstanding does Sinopharm Group Co Ltd Class H have?

Sinopharm Group Co Ltd Class H has 1,341,810,800 shares outstanding.

What happened to Sinopharm Group Co Ltd Class H’s price movement after its last earnings report?

Sinopharm Group Co Ltd Class H reported an EPS of HK$0.505 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.457%.

Which hedge fund is a major shareholder of Sinopharm Group Co Ltd Class H?

Currently, no hedge funds are holding shares in HK:1099

Sinopharm Group Co Stock Smart Score

Neutral

Fundamentals

Return on Equity

9.19%

Trailing 12-Months

Asset Growth

-0.45%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Sinopharm Group Co Ltd Class H

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

1099 Stock 12 Month Forecast

Average Price Target

HK$23.38

▲(25.03%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"15":"HK$15","26":"HK$26","17.75":"HK$17.75","20.5":"HK$20.5","23.25":"HK$23.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23.400000009653905,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$23.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.3811679696,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$23.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":23.400000009653905,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$23.40</span>\n  </div></div>","useHTML":true}}],"tickPositions":[15,17.75,20.5,23.25,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2023","6":"Mar<br/>2024","9":"Oct<br/>2024","12":"Mar<br/>2025","25":"Mar<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.58,19.87384615458876,20.16769230917752,20.461538463766285,20.755384618355045,21.049230772943808,21.34307692753257,21.63692308212133,21.930769236710095,22.224615391298855,22.518461545887618,22.81230770047638,23.10615385506514,{"y":23.400000009653905,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.58,19.872397536123074,20.164795072246154,20.45719260836923,20.749590144492306,21.041987680615385,21.33438521673846,21.626782752861537,21.919180288984613,22.211577825107693,22.50397536123077,22.796372897353848,23.088770433476924,{"y":23.3811679696,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.58,19.87384615458876,20.16769230917752,20.461538463766285,20.755384618355045,21.049230772943808,21.34307692753257,21.63692308212133,21.930769236710095,22.224615391298855,22.518461545887618,22.81230770047638,23.10615385506514,{"y":23.400000009653905,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.367,"date":1635724800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.755,"date":1646092800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.718,"date":1682899200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.437,"date":1688169600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.099,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.348,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.62,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.44,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.8,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.55,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.1,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.58,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >